Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             177 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Catalytic 3D Model Development of HIV-Integrase and Drug Resistance Understanding by Molecular Dynamics Simulation Sharon, Ashoke
 2011
 90 2 p. A43-A44
nvt p.
 artikel
2 A Comparison of the ability of wild-type and S282T mutant HCV NS5B to incorporate 2′-α-F-2′-β-C-methylguanosine-5′-monophosphate and 2′-α-OH-2′-β-C-methylguanosine-5′-monophosphate Murakami, Eisuke
 2011
 90 2 p. A73-
1 p.
 artikel
3 A Computational Approach to Search Active Peptides as Membrane Fusion Inhibitors of HIV-1 Tian, Yu-Shi
 2011
 90 2 p. A76-A77
nvt p.
 artikel
4 Activities of Viral M2 Channel, Neuraminidase, and RNA Polymerase Inhibitors on Oseltamivir-Resistant H275Y Influenza A (H1N1) Virus Infections in Mice Smee, Donald F.
 2011
 90 2 p. A27-
1 p.
 artikel
5 Activity of Novel Cyclophilin Inhibitors based on the Polyketide, Sanglifehrin A, against HIV Bobardt, Michael
 2011
 90 2 p. A29-
1 p.
 artikel
6 Acyclic Nucleoside Phosphonates: Past, Present, and Future 2011
 90 2 p. A70-
1 p.
 artikel
7 Adenosine Deaminase-like Protein 1 (ADAL1) Catalyzes Removal of Different Alkyl Groups from N 6- or O 6-substituted Purine or 2-Aminopurine Nucleoside Monophosphates Murakami, Eisuke
 2011
 90 2 p. A60-
1 p.
 artikel
8 Amido tyrosine esters: a promising new approach to antiviral nucleoside phosphonate prodrugs McKenna, Charles E.
 2011
 90 2 p. A23-A24
nvt p.
 artikel
9 Amino Acid Substitutions At Residue 207 of Viral Capsid Protein 1 (VP1) Confer Pleconaril Resistance in Coxsackievirus B3 (CVB3) Braun, Heike
 2011
 90 2 p. A54-A55
nvt p.
 artikel
10 An Analogue of the Antibiotic Teicoplanin Inhibits Dengue Virus Entry In Vitro De Burghgraeve, Tine
 2011
 90 2 p. A31-
1 p.
 artikel
11 An Antiviral Assay to Identify Inhibitors of the Human Metapneumovirus that is Amenable for High-throughput Screening Purposes Leyssen, Pieter
 2011
 90 2 p. A36-
1 p.
 artikel
12 2′- and 4′-Modified Ribonucleoside Analogs Can Inhibit All Four Serotypes of Dengue Virus in Human Primary Dendritic Cells as Competitive Inhibitors and Non-obligatory Chain Terminators Javanbakht, Hassan
 2011
 90 2 p. A26-
1 p.
 artikel
13 A Novel Family of Multivalent Compounds able to Interact with GP120: Anti-HIV Evaluation and Binding Analysis With Surface Plasmon Resonance Lozano, Virginia
 2011
 90 2 p. A72-
1 p.
 artikel
14 A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE Jochmans, Dirk
 2011
 90 2 p. A33-A34
nvt p.
 artikel
15 Antiadenoviral Assay, Based on the Quantitative Detection of Infected Cells Containing Virus-induced Intranuclear Inclusion Bodies Nosach, Lidiya N.
 2011
 90 2 p. A61-
1 p.
 artikel
16 Antiarboviral Efficacy of Combined Application of Interferon Inducers and Proteolysis Inhibitor Kozlovsky, Mykhajloik
 2011
 90 2 p. A35-A36
nvt p.
 artikel
17 Anti-EBV Activity of Hemocyanin Isolated from Helix Lucorum Zagorodnya, Svitlana D.
 2011
 90 2 p. A66-
1 p.
 artikel
18 Anti-HBV Activities of Novel 2′,3′-C-substituted beta-l-nucleoside Analogues Zhou, Xiao-Xiong
 2011
 90 2 p. A78-
1 p.
 artikel
19 Anti-HCV Drug Development 2011
 90 2 p. A72-
1 p.
 artikel
20 Antiherpes Activities of Some Medical Plants from the Lamiaceae Kostova, Kalina A.
 2011
 90 2 p. A56-
1 p.
 artikel
21 Antiviral Activity of a Thioglycoside Derivative Mimicking Tunicamycin Structure Krol, Ewelina
 2011
 90 2 p. A57-
1 p.
 artikel
22 Antiviral Activity of Carbohydrate-containing Biopolymers of Pseudomonas chlororaphis subsp. aureofaciens Shepelevitch, Victoria V.
 2011
 90 2 p. A64-
1 p.
 artikel
23 Antiviral Activity of Cymbopogon nardus (L.) Rendle Fractions Against HSV-1 Bahtiar, Adibah A.
 2011
 90 2 p. A54-
1 p.
 artikel
24 Antiviral Activity of Hemocyanin Isolated from Marine Snail Rapana venosa Nesterova, Nadiya V.
 2011
 90 2 p. A38-
1 p.
 artikel
25 Antiviral Activity of the MEK-inhibitor U0126 against Pandemic H1N1v and Highly Pathogenic Avian Influenza Virus In Vitro and In Vivo Droebner, Karoline
 2011
 90 2 p. A32-
1 p.
 artikel
26 Antiviral Activity of the Proteasome Inhibitor VL-01 against Human and Avian Influenza A Viruses 2011
 90 2 p. A33-
1 p.
 artikel
27 Antiviral Drug-Resistant Influenza Viruses in Gyeonggi Province, South Korea, from 2005 to 2010 Cho, Hangil
 2011
 90 2 p. A30-
1 p.
 artikel
28 Antiviral Effectivity of Ceria Colloid Solutions Zholobak, Nadiya
 2011
 90 2 p. A67-
1 p.
 artikel
29 Antiviral Effect of Molluscan Haemocyanines Velkova, Lyudmila
 2011
 90 2 p. A47-A48
nvt p.
 artikel
30 Antiviral Effect of Oxoglaucine in Combination with Some Enterovirus Replication Inhibitors Nikolaeva-Glomb, Lubomira
 2011
 90 2 p. A61-
1 p.
 artikel
31 Antiviral Effect of the Sulfated Polysaccharide, p-KG03, Against Influenza A Virus Kim, Meehyein
 2011
 90 2 p. A34-A35
nvt p.
 artikel
32 Anti-viral Properties and Mode of Action of Standardized Echinacea purpurea Extract Against Highly Pathogenic Avian Influenza Virus (H5N1, H7N7) and Swine-origin H1N1 (S-OIV) Pleschka, Stephan
 2011
 90 2 p. A39-
1 p.
 artikel
33 Antiviral Properties of New Cage Compounds Klimochkin, Yuri
 2011
 90 2 p. A71-
1 p.
 artikel
34 Arenaviruses and hantaviruses: From epidemiology and genomics to antivirals Charrel, R.N.
 2011
 90 2 p. 102-114
13 p.
 artikel
35 A viable Human Influenza A Virus Lacking Neuraminidase (NA) Activity-isolation and Characterization Richter, Martina
 2011
 90 2 p. A52-
1 p.
 artikel
36 Avoidance of Coxsackievirus Drug Resistance by Using a Novel Scheme of Combining Anti-Enteroviral Inhibitors In Vivo Vassileva-Pencheva, Ralitsa
 2011
 90 2 p. A47-
1 p.
 artikel
37 Beta5 integrin is the major contributor to the alphaV integrin-mediated blockade of HIV-1 replication Ballana, Ester
 2011
 90 2 p. A23-
1 p.
 artikel
38 Classical Swine Fever Outbreak Containment – Antivirals as an Epidemiologically and Economically Viable Alternative to Emergency Vaccination and Culling Ribbens, Stefaan
 2011
 90 2 p. A40-
1 p.
 artikel
39 CMX001 (Hexadecyloxypropyl Cidofovir) Antiviral Activity against Adenovirus in Patients Correlates with Drug Levels and Viral Sensitivity Lanier, E.R.
 2011
 90 2 p. A27-A28
nvt p.
 artikel
40 CMX001 Potentiates the Efficacy of Acyclovir in Herpes Simplex Virus Infections Prichard, Mark
 2011
 90 2 p. A25-
1 p.
 artikel
41 Combinatorial Anti-arenaviral Therapy with the Small Molecule SKI-1/S1P Inhibitor PF-429242 and Ribavirin Pasquato, Antonella
 2011
 90 2 p. A62-
1 p.
 artikel
42 Combine Action Rimantadine and Amizon on Flu Occasion Danilenko, G.
 2011
 90 2 p. A31-
1 p.
 artikel
43 Combined Anti-influenza Virus Effect of Natural and Synthetic Viral Inhibitors Serkedjieva, Julia
 2011
 90 2 p. A43-
1 p.
 artikel
44 Computer-aided Design and Evaluation of Novel Anti-CHIKV Compounds Bassetto, Marcella
 2011
 90 2 p. A67-
1 p.
 artikel
45 Control of HIV-infection with Visits Scheduled Every Four or Every Six Months. A Comparative Randomized Study Roca, Bernardno
 2011
 90 2 p. A41-
1 p.
 artikel
46 Cost Effective Rapid Virological Response Guided Peginterferon Therapy Plan in HCV Genotype 3 Pakistani Population Aziz, Hafsa
 2011
 90 2 p. A53-A54
nvt p.
 artikel
47 Coumarins Hybridized with Heterocycles or Ribonucleosides for Eradication of Hepatitis C Virus Hwu, Reuben Jih-Ru
 2011
 90 2 p. A69-
1 p.
 artikel
48 Crimean Congo Haemorrhagic Fever Virus: An Emerging Concern for Iran's Public Health Chinikar, Sadegh
 2011
 90 2 p. A30-
1 p.
 artikel
49 Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies Keshtkar-Jahromi, Maryam
 2011
 90 2 p. 85-92
8 p.
 artikel
50 Cyclopropavir Inhibits the Normal Function of the Human Cytomegalovirus UL97 Kinase Prichard, Mark
 2011
 90 2 p. A24-
1 p.
 artikel
51 Design and Synthesis of New Isatin Derivatives as HIV-1 Reverse Transcriptase Associated Ribonuclease H Inhibitors Esposito, Francesca
 2011
 90 2 p. A32-
1 p.
 artikel
52 Design, Synthesis, and Anti-HCV Activity of 2′-Modified-4′-selenonucleosides Jeong, Lak Shin
 2011
 90 2 p. A70-
1 p.
 artikel
53 Design, Synthesis and West Nile Protease Inhibitory Activity of Novel Isatin Derivatives Selvam, Periyasamy
 2011
 90 2 p. A28-
1 p.
 artikel
54 Development of Antimicrobial Peptides as Topical Microbicides for the Prevention of HIV Watson, Karen M.
 2011
 90 2 p. A48-A49
nvt p.
 artikel
55 Development of Novel Evaluation Method to Anti-influenza Drug Resistance using Docking Study Kawashita, Norihito
 2011
 90 2 p. A71-
1 p.
 artikel
56 Differential Expression of Host Cellular Factors upon HIV-1 Reactivation Suarez, Paula Ordonez
 2011
 90 2 p. A51-
1 p.
 artikel
57 3′,5′di-O-Trityluridine Inhibits Flavivirus (Dengue and Yellow Fever Virus) Replication and Targets the Viral RNA Dependent RNA Polymerase De Burghgraeve, Tine
 2011
 90 2 p. A55-
1 p.
 artikel
58 Dioxolane l-Nucleoside Analogs Prevent Varicella-Zoster Virus Replication in Fibroblasts and Skin Organ Culture De, Chandrav
 2011
 90 2 p. A49-A50
nvt p.
 artikel
59 Discovery and Development of Orally Active Antivirals for the Treatment of RSV: Identification of BTA9881 and a 2nd Generation Candidate Tucker, Simon
 2011
 90 2 p. A46-A47
nvt p.
 artikel
60 Discovery of Novel Natural Neuraminidase Inhibitors (NAI) based on In Silico Screening and Antiviral Investigations Schmidtke, Michaela
 2011
 90 2 p. A42-
1 p.
 artikel
61 DMPK and Metabolism Studies of Nucleoside Phosphoramidates Including INX-08189, A Novel Double Pro-drug and Clinical Candidate for Hepatitis C Virus Therapy Hutchins, Jeff T.
 2011
 90 2 p. A22-A23
nvt p.
 artikel
62 Doxycycline in Tick-borne Encephalitis Virus Infection Kozlovskaya, Liubov
 2011
 90 2 p. A35-
1 p.
 artikel
63 dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35 Zinzula, Luca
 2011
 90 2 p. A49-
1 p.
 artikel
64 Editorial Board 2011
 90 2 p. ii-
1 p.
 artikel
65 Effective Prophylactic and Therapeutic Treatment of Yellow Fever Virus with an Adenovirus-vectored Interferon, DEF201, in a Hamster Model Julander, Justin G.
 2011
 90 2 p. A34-
1 p.
 artikel
66 Effective Treatment Plan for G3 Patients 2011
 90 2 p. A53-
1 p.
 artikel
67 Effect of Molecular Symmetry on Potency in Novel Down-Modulators of the CD4 Receptor Bell, Thomas W.
 2011
 90 2 p. A68-
1 p.
 artikel
68 Effects of the Addition of Hiltonol® (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model Barnard, Dale L.
 2011
 90 2 p. A28-
1 p.
 artikel
69 Efficacy of Aminocaproic Acid use for Prevention of Some Infectious Diseases in Organized Collectives Trihleb, V.
 2011
 90 2 p. A45-A46
nvt p.
 artikel
70 Efficacy of Zanamivir Administered by Different Routes and at Different Times for Treatment of an Influenza A/CA/04/2009 (H1N1) Virus Infection in Mice Tarbet, Bart
 2011
 90 2 p. A45-
1 p.
 artikel
71 Ellagitannins as New Highly Efficient Inhibitors of Herpes Simplex Virus Replication and Synergists of Acyclovir Vilhelmova, Nelly
 2011
 90 2 p. A64-A65
nvt p.
 artikel
72 Engineering Genetic Suppressor Elements against Hepatits C Virus Chen, Zhilei
 2011
 90 2 p. A55-
1 p.
 artikel
73 Enhanced Cellular Penetration of ODE-(S)-MPMPA Accounts for Its Prolonged Post-exposure Anti-HCV Activity Wyles, David L.
 2011
 90 2 p. A65-A66
nvt p.
 artikel
74 European Consortium on Antiviral Drug Development: SILVER Romette, Jean-Louis
 2011
 90 2 p. A63-
1 p.
 artikel
75 European Training Network on (+)RNA Virus Replication and Antiviral Drug Development van Kuppeveld, Frank
 2011
 90 2 p. A64-
1 p.
 artikel
76 European Virus Archive Romette, Jean-Louis
 2011
 90 2 p. A41-
1 p.
 artikel
77 Evaluation of Approved Antivirals for Inhibition of Xenotropic Murine Leukemia-Related Virus (XMRV) in Cell-Based Assays Hartman, Tracy L.
 2011
 90 2 p. A50-
1 p.
 artikel
78 Excision of AZT and d4T Modulated by Deletions in the β3–β4 Hairpin Loop of HIV-1 Reverse Transcriptase Kisic, Mónica
 2011
 90 2 p. A35-
1 p.
 artikel
79 Favipiravir (T-705) Treatment of Experimental Arenaviral Infection Initiated after the Onset of Clinical Disease Gowen, Brian B.
 2011
 90 2 p. A52-
1 p.
 artikel
80 Generation of dsRNAs Targeting VP1 and VP3 Gene Regions of Coxsackievirus B1 Utilizing Bacteriophage ф6 Polymerase Complex Petrov, Nikolay M.
 2011
 90 2 p. A62-
1 p.
 artikel
81 Genome Specific Diagnosis of Influenza Virus Strains by Hairpin-type Peptide Nucleic Acid Kaihatsu, Kunihiro
 2011
 90 2 p. A70-
1 p.
 artikel
82 Hepatitis C Virus Vaccine Candidates from Chimeric Hepatitis B Core Virus-like Particles Carrying Different Fragments of HCV Non-structural Protein 3 Mihailova, Marija
 2011
 90 2 p. A59-
1 p.
 artikel
83 Hepatitis E Virus (HEV) Proteome and RNA Silencing Suppressors (RSS): A Search Kumar, Amit
 2011
 90 2 p. A57-
1 p.
 artikel
84 Herpes Simplex Virus Thymidine Kinase Inhibitor GLS122E and Its 6-Deoxy Prodrug GLS361B (Sacrovir™)—Potential for Preventing Viral Disease Recurrence In Vivo Yanachkov, Ivan B.
 2011
 90 2 p. A77-A78
nvt p.
 artikel
85 HIV Full-Replication Technology for Identification of Novel HIV Inhibitors from Multiple Sources Kremb, Stephan
 2011
 90 2 p. A36-
1 p.
 artikel
86 HLA-C-35C/T Variant: Genetic Association to HIV-1 Disease Progression and Functional Links Ruiz, Alba
 2011
 90 2 p. A41-A42
nvt p.
 artikel
87 HSV-1 and Alzheimer's Disease: The Case for Antiviral Treatment 2011
 90 2 p. A69-
1 p.
 artikel
88 Human Papillomavirus Genotype Distribution in Women in Montenegro Vujošević, Danijela
 2011
 90 2 p. A65-
1 p.
 artikel
89 Human subtilase Site-1 Protease (S1P): An Emerging Host Cell Target for Hepatitis C Virus (HCV) Infection and HCV-associated Steatogenesis Olmstead, Andrea D.
 2011
 90 2 p. A22-
1 p.
 artikel
90 Identification and Characterization of Azolo-1,3-benzoxazines and Condensed Benzopyrans as Potent Non-nucleoside Inhibitors of Orthopoxviruses Klimochkin, Yuri
 2011
 90 2 p. A50-
1 p.
 artikel
91 Identification and Characterization of OBR-5-340 – A Novel Broad-spectrum Anti-human Rhinovirus (HRV) Inhibitor Richter, Martina
 2011
 90 2 p. A40-
1 p.
 artikel
92 Identification of Alphavirus Inhibitors by Using Virus-Based Assays and a Chikungunya Replicon Cell Line Ahola, Tero
 2011
 90 2 p. A52-A53
nvt p.
 artikel
93 Identification of a Novel Antiviral Drug Targeting at Host Apoptotic Responses Gu, Linlin
 2011
 90 2 p. A55-
1 p.
 artikel
94 Identification of Bicyclic Sulfone Inhibitors of HHV-6 Targeting the HHV-6 U77 Helicase Naesens, Lieve
 2011
 90 2 p. A60-A61
nvt p.
 artikel
95 Identification of HIV-1 Reverse Transcriptase Dual Inhibitors by a Combined Shape-, 2D-Fingerprint- and Pharmacophore-based Virtual Screening Approach Distinto, Simona
 2011
 90 2 p. A31-
1 p.
 artikel
96 Identification of New Druggable Antiviral Targets by Chemical Genetics Kao, Richard Y.
 2011
 90 2 p. A27-
1 p.
 artikel
97 IDX375, A Novel Allosteric HCV Polymerase Inhibitor: In Vitro Antiviral Activity and Preclinical Profile Dousson, C.B.
 2011
 90 2 p. A21-
1 p.
 artikel
98 Impact of HIV Coinfection on State of Immunology of Patients with Chronic HCV-Infection Matsieuskaya, Natallia V.
 2011
 90 2 p. A58-
1 p.
 artikel
99 Important Role for Protein Kinase C-α in Combined Pneumolysin/Influenza A Virus-induced Pulmonary Endothelial Hyperpermeability Vergara-Alert, Júlia
 2011
 90 2 p. A26-
1 p.
 artikel
100 Inactivated Vaccine Against Tick-Borne Encephalitis Virus as Surrogate Vaccine Against Omsk Hemorrhagic Fever Virus Terekhina, Liubov
 2011
 90 2 p. A45-
1 p.
 artikel
101 Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at the Indole-2-carboxamide La Regina, Giuseppe
 2011
 90 2 p. A71-A72
nvt p.
 artikel
102 Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid Vázquez-Calvo, Angela
 2011
 90 2 p. A47-
1 p.
 artikel
103 Inhibition of Herpes- and Adenovirus Replication by Extract of Artemia salina Cysts from Crimean Hypersaline Lakes Povnitsa, Olga Yu.
 2011
 90 2 p. A62-
1 p.
 artikel
104 Inhibition of Human Cytomegalovirus Replication by Tricin (4′,5,7-Trihydroxy-3′,5′-dimethoxyflavone) Murayama, Tsugiya
 2011
 90 2 p. A60-
1 p.
 artikel
105 Inhibition of Influenza Virus-induced NF-kB and ERK Activation can Simultaneously Reduce Both, Virus Titres and Cytokine Expression In Vitro and In Vivo Pinto, Ruth
 2011
 90 2 p. A51-
1 p.
 artikel
106 In silico Screening of Compounds Targeting Human Cyclin T1 and In vitro Evaluation of their Anti-HIV-1 Activity Hamasaki, Takayuki
 2011
 90 2 p. A33-
1 p.
 artikel
107 Intravitreal Alkoxyalkyl Esters of Cyclic Cidofovir for Treatment of Ocular Viral Infections Beadle, James R.
 2011
 90 2 p. A68-
1 p.
 artikel
108 Investigation of Anti-EBV Activity of Ganciclovir in Combination with Antiflogistics Zagorodnya, Svitlana D.
 2011
 90 2 p. A66-
1 p.
 artikel
109 Investigation of the Effects on Early Secretory Pathway in Cultured Cells and Potential Application of Antiviral Substances Levakova, V.
 2011
 90 2 p. A57-
1 p.
 artikel
110 Invitation to "The Twenty-Fourth International Conference on Antiviral Research" 2011
 90 2 p. A83-A84
nvt p.
 artikel
111 In Vitro Combination Therapy with Tegobuvir (GS-9190) is Highly Efficient in Curing Cells from HCV Replicon and in Delaying/Preventing the Development of Antiviral Resistance Vliegen, Inge
 2011
 90 2 p. A65-
1 p.
 artikel
112 In-vitro Screening for Compounds Active Against Polyomavirus BK: A Seven Year Experience Parmjeet, S.
 2011
 90 2 p. A63-
1 p.
 artikel
113 In vitro Selection of HCV Replicons with Reduced Sensitivity to PSI-352938, A Cyclicphosphate Prodrug of β-d-2′-α-F-2′-β-C-Methylguanosine Lam, Angela M.
 2011
 90 2 p. A22-
1 p.
 artikel
114 In Vivo Efficacy of N-methanocarbathymidine (N-MCT) against Herpes simplex Virus Type 2 in Neonatal Guinea Pigs Cardin, Rhonda
 2011
 90 2 p. A24-A25
nvt p.
 artikel
115 Long-term Inhibition of HIV-1 Replication in CD4+ T Cells Transduced with a Retroviral Vector Conditionally Expressing the Escherichia coli Endoribonuclease MazF Okamoto, Mika
 2011
 90 2 p. A38-
1 p.
 artikel
116 Mechanism of HIV-1 Neutralization by an Antibody: Reversible Binding Stalls Entry Kabat, David
 2011
 90 2 p. A23-
1 p.
 artikel
117 Mechanistic Studies on a Novel Hydrophobic Derivative of Aglycoristocetin with Potent and Broad Activity Against Influenza Viruses Vanderlinden, Evelien
 2011
 90 2 p. A47-
1 p.
 artikel
118 New Antiviral Substances of Indoloquinoxaline and Diphenyl Nature Antonovych, Georgiy V.
 2011
 90 2 p. A53-
1 p.
 artikel
119 New Caledonian Plants As A Source of Dengue Virus Inhibitors Guillemot, Jean-Claude
 2011
 90 2 p. A56-
1 p.
 artikel
120 New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B Rai, Roopa
 2011
 90 2 p. 93-101
9 p.
 artikel
121 Nitazoxanide is an Indirect Inhibitor of HCV Replication Through Modulation of Cellular Kinase CKI Alpha to Enhance HCV NS5A Hyperphosphorylation Montero, Abigail
 2011
 90 2 p. A59-
1 p.
 artikel
122 Notes to Authors 2011
 90 2 p. CO3-
1 p.
 artikel
123 Novel Chemical Compounds as Potential Blockers to the Swine-Origin Influenza A H1N1 (2009) Virus Replication Rajput, Roopali
 2011
 90 2 p. A39-
1 p.
 artikel
124 Novel Derivatives of Abacavir – Synthesis and Activity Against Human Immunodeficiency Virus-Type 1 in Cell Culture Stanoeva, Kamelia R.
 2011
 90 2 p. A44-A45
nvt p.
 artikel
125 Novel Inhibitors of Nuclear Translocation of HIV-1 Integrase Wagstaff, Kylie
 2011
 90 2 p. A48-
1 p.
 artikel
126 Novel 2-Styryl-8-hydroxyquinolines (8SQs) Derivatives with Anti-HIV-1 Activity Targeting Viral Integrase and Protease Hinkov, Anton V.
 2011
 90 2 p. A33-
1 p.
 artikel
127 OBR-5-340—A Novel Pyrazolo-Pyrimidine Derivative with Strong Antiviral Activity Against Coxsackievirus B3 In Vitro and In Vivo Braun, Heike
 2011
 90 2 p. A29-
1 p.
 artikel
128 Occurrence of Opportunistic Infections in People Living with HIV/AIDS Following Antiretroviral Therapy in West Bengal, India Chakraborty, Sayan
 2011
 90 2 p. A29-A30
nvt p.
 artikel
129 Oseltamivir Influences Hepatic Cytochrome P-450 Dependent Oxidative Metabolism in Influenza Virus Infected Mice Mileva, Milka M.
 2011
 90 2 p. A37-A38
nvt p.
 artikel
130 2009 Pandemic Influenza Virus: What Special for its HA and NA? Gao, George F.
 2011
 90 2 p. A26-
1 p.
 artikel
131 Pegasys As A Second Line of Effective Treatment Plan for G3 Non Responders of Conventional Therapy Arshad, Binish G.
 2011
 90 2 p. A53-
1 p.
 artikel
132 Phosphoramidate Dinucleosides as Inhibitors of Hepatitis C Virus Subgenomic Replicon and NS5B Polymerase Activity Priet, S.
 2011
 90 2 p. A75-
1 p.
 artikel
133 Photodynamic Effect of Phthalocyanine–Zn (II) Complexes on Some Enveloped Viruses Remichkova, M.
 2011
 90 2 p. A39-A40
nvt p.
 artikel
134 PHYTOCHIK: Biodiversity As A Source of Selective Inhibitors of CHIKV Replication Leyssen, Pieter
 2011
 90 2 p. A36-A37
nvt p.
 artikel
135 Polymer-cooperative Approach to Multi-blocking the Viruses Serbin, A.
 2011
 90 2 p. A76-
1 p.
 artikel
136 Polymer-coupled Systems for Blocking the Viral Fusion 1. Modeling in silico the in vitro HIV-1 Entry Inhibitors Tsvetkov, V.
 2011
 90 2 p. A46-
1 p.
 artikel
137 Prophylactic Activity of mDEF201 Against Vaccinia Virus Respiratory Infections in Mice Smee, Donald F.
 2011
 90 2 p. A44-
1 p.
 artikel
138 QSAR Analysis of Anti-influenza (A/H1N1) Activity of Azolo-adamantanes Muratov, Eugene
 2011
 90 2 p. A74-
1 p.
 artikel
139 Recycling of HIV Particles is Required for Infection by Endocytosed Virus after Cell to Cell Transfer Permanyer, Marc
 2011
 90 2 p. A51-
1 p.
 artikel
140 Relationship Between Homocysteine Serum Level and Other Blood Analyses Parameters in HIV-infected Patients Roca, Bernardino
 2011
 90 2 p. A40-A41
nvt p.
 artikel
141 Rigid Amphipathic Fusion Inhibitors (RAFIs) Inhibit Infectivity of Enveloped Viruses by Targeting Envelope Lipids to Prevent Fusion With Cellular Membranes Colpitts, Che C.
 2011
 90 2 p. A30-A31
nvt p.
 artikel
142 RNA Interference Mediated Gene Silencing of Influenza A Virus: A Tool for Potent Antiviral Therapy Khanna, Madhu
 2011
 90 2 p. A34-
1 p.
 artikel
143 Role of Cathepsin A and Lysosomes in the Intracellular Activation of Novel Anti-papillomavirus Agent GS-9191 Birkus, Gabriel
 2011
 90 2 p. A49-
1 p.
 artikel
144 Safety and Human Pharmacokinetics of AIC316, a Potent Helicase-Primase Inhibitor of Herpes Simplex Virus (HSV) Birkmann, Alexander
 2011
 90 2 p. A25-
1 p.
 artikel
145 Silibinin Abolish the Enhanced Expression of Fibrosis-Related Molecules Caused by Hepatitis C Virus E2 Protein Hsieh, Ming-Ju
 2011
 90 2 p. A56-
1 p.
 artikel
146 SP600125 Inhibits Orthopoxviruses Replication on a JNK1/2-Independent Manner – Implication as a Potential Anti-Poxviral Pereira, Anna C.P.
 2011
 90 2 p. A38-A39
nvt p.
 artikel
147 Stereoselective Synthesis of Different Types of Nucleotide Prodrugs Meier, Chris
 2011
 90 2 p. A73-
1 p.
 artikel
148 Structural and functional characterization of human cytomegalovirus terminase leads to a new antiviral target Nadal, Marta
 2011
 90 2 p. A24-
1 p.
 artikel
149 Structure-based design of small-molecules that selectively inhibit dengue virus methyltransferase Noble, Christian G.
 2011
 90 2 p. A74-
1 p.
 artikel
150 Studies of HIV Integrase Inhibitory Activity of Novel Isatine Derivatives Selvam, Periyasamy
 2011
 90 2 p. A43-
1 p.
 artikel
151 Studies on Anti-HSV Activity and Cytotoxicity of Morinda citrifolia L. Noni Leaf Selvam, Periyasamy
 2011
 90 2 p. A63-A64
nvt p.
 artikel
152 Study of NS5B Oligomerization by FRET: Characterization and Inhibition Bellón-Echeverría, Itxaso
 2011
 90 2 p. A21-A22
nvt p.
 artikel
153 Styrylpyrone Derivative of Goniothalamus umbrosus Inhibit HSV-1 Infection During Viral Early Replication Cycle Md Nor, Norefrina S.
 2011
 90 2 p. A58-
1 p.
 artikel
154 Susceptibility to Neuraminidase Inhibitors and M2 Blockers of Some Seasonal Influenza Strains Isolated in Bulgaria 2004–2007 Simeonova, Lora
 2011
 90 2 p. A44-
1 p.
 artikel
155 Synthesis and Anti-HIV Activity of d-peptide Analogs as HIV Fusion Inhibitors Baron, Alice
 2011
 90 2 p. A28-A29
nvt p.
 artikel
156 Synthesis and Antiviral Activity of 3-Methoxy-2-(phosphonomethoxy)propyl Nucleoside Esters Against HCV and HIV-1 Valiaeva, Nadejda
 2011
 90 2 p. A77-
1 p.
 artikel
157 Synthesis and Antiviral Evaluation of N9-[2-(Phosphonomethoxy)ethyl] (PME) Analogues Derived from 8-Substituted Purines Janeba, Zlatko
 2011
 90 2 p. A69-A70
nvt p.
 artikel
158 Synthesis and evaluation of biological activity of new aminoadamantane amides containing hydroxycinnamoyl moiety Chochkova, Maya G.
 2011
 90 2 p. A69-
1 p.
 artikel
159 Synthesis and In Vitro Anti-influenza Activity of New Amino Acids and Peptidomimetics Derivatives of Oseltamivir and Rimantadine Stankova, Ivanka
 2011
 90 2 p. A76-
1 p.
 artikel
160 Synthesis, Anti-HIV and Cytotoxic Activity of Some Novel Isatine-Sulfisomidine Derivatives Selvam, Periyasamy
 2011
 90 2 p. A42-
1 p.
 artikel
161 Synthesis, Influence of Polymer Molecular Weight on Drug Release and Anti-HIV Activity of PEGylated AZT Conjugates Li, Wenjun
 2011
 90 2 p. A37-
1 p.
 artikel
162 Synthesis of Novel CADA Analog Prodrugs Designed as Down-Modulators of the CD4 Receptor Scarbrough, Emily D.
 2011
 90 2 p. A75-A76
nvt p.
 artikel
163 Targeted Elimination of HIV Infected Cells: Synergistic Combination of Dexamethasone and DEAE as a Paradigm Elbourkadi, Najoua
 2011
 90 2 p. A32-
1 p.
 artikel
164 Targeting HCV (+) Strand RNA Genome by a Novel PNA–neamine Conjugate Manvar, Dineshkumar
 2011
 90 2 p. A72-
1 p.
 artikel
165 Targeting the Flavivirus Helicase Mastrangelo, Eloise
 2011
 90 2 p. A72-A73
nvt p.
 artikel
166 The Crimean Congo Hemorrhagic Fever European Consortium: Modern Approaches to Diagnostics, Epidemiology, Prevention, Therapy and Preparedness Mirazimi, Ali
 2011
 90 2 p. A59-
1 p.
 artikel
167 The Design and Synthesis of Pyrolle-Carbaldehydes as HIV-1 Integrase Strand-Transfer Inhibitors Hewer, Raymond
 2011
 90 2 p. A50-
1 p.
 artikel
168 The 3D-Screen Technology, an Innovative Cell-based Assay to Identify Modulators that Alter Target Protein Conformation: Example with HCV Valarche, Isabelle
 2011
 90 2 p. A77-
1 p.
 artikel
169 The Protective Action Arbivirin and Aminocaproic Acid during the Experimental Influenza Lozitsky, V.
 2011
 90 2 p. A37-
1 p.
 artikel
170 The Twenty-Fourth International Conference on Antiviral Research - Author Index 2011
 90 2 p. A79-A82
nvt p.
 artikel
171 Thiazolylthioacetamides as a Novel Class of Potential Antiviral Agents Zhan, Peng
 2011
 90 2 p. A67-
1 p.
 artikel
172 Tick-borne Flaviviruses Infection in Non-human Primates Rogova, Yulia
 2011
 90 2 p. A75-
1 p.
 artikel
173 Tripartate Prodrugs of Hydroxy-containing Compounds Camarasa, María-José
 2011
 90 2 p. A68-A69
nvt p.
 artikel
174 Triterpenoids from Platycodon grandiflorum Inhibit Hepatitis C Virus Replication Park, Sang Jin
 2011
 90 2 p. A61-A62
nvt p.
 artikel
175 Twenty-Fourth International Conference on Antiviral Research - Front Pages 2011
 90 2 p. A1-A20
nvt p.
 artikel
176 Viral Genome Dynamics During Antiviral Resistance Selection: A First Glimpse into Viral Evolution Musiu, Simone
 2011
 90 2 p. A74-
1 p.
 artikel
177 Virucidal Activity of Calluses’ Extracts from Tobacco-Plants Lozitsky, V.
 2011
 90 2 p. A57-A58
nvt p.
 artikel
                             177 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland